Regular screening for prostate cancer with the prostate-specific antigen (PSA) test did not reduce deaths from the disease after 7 years of follow up, according to the long-awaited results from two large randomized trials, one conducted in the United States and the other in Europe. Read more > >
The striking similarities between stem cells in normal tissue that are responsible for continuously replacing adult tissues and a very small subset of cells found in growing tumors have sparked considerable interest in the research community. As a result, there is perhaps no better time for cancer biologists to draw on the considerable knowledge of our colleagues in embryology and developmental biology to explore questions about the initiation and progression of cancer—and potentially to understand how it develops resistance to therapies and how it metastasizes. Read more > >
The director of NCI's Office of Latin American Cancer Program Development discusses the office's plans and goals Read more > >
- In Memoriam: Former NCI Director Dr. Carl Baker
- CTCAE 4.0 Posted for Public Review
- Free Telephone Workshop Series for Cancer Survivors
- Registration Open for Neuropathic Cancer Pain Symposium
- NCI Hosts International Art Exchange Exhibit
- Robotic Surgery Featured in BenchMarks
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at firstname.lastname@example.org.